Articles Archive - Page 670 of 817

ACR/ARHP Annual Meeting 2012: Identify Compliance Risks to Avoid Violating Medicare Rules

Mary Beth Nierengarten | January 1, 2013

Rheumatologists should develop a plan to keep in step with federal regulations

ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?

Thomas R. Collins | January 1, 2013

Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins | January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

Was Gout Rampant Among the Romans?

Simon M. Helfgott, MD | January 1, 2013

Lead in wine consumed by Romans may have contributed to a high incidence of gout among aristocrats of the Roman Empire

ACR/ARHP Annual Meeting 2012: Global Perspectives Make Rheumatology Meeting an International Affair

Susan Bernstein | January 1, 2013

Attendees from every corner of the world came to the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting with different educational and professional goals

ACR/ARHP Annual Meeting 2012: How to Manage Gout Effectively in the Context of Comorbid Conditions

Mary Beth Nierengarten | January 1, 2013

Comorbid conditions such as chronic kidney disease and cardiovascular disease can complicate gout management, but effective treatment and preventive strategies are available

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | January 1, 2013

Information on new approvals and medication safety rheumatologists need to know

BU’s New ENACT Arthritis Research Training and Outreach Program Off to Successful Start

Michael O’Neal | December 3, 2012

A new research training program at the Boston University is making a profound impact on the Greater Boston arthritis community.

What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Aryeh Fischer, MD, and Jeff Swigris, DO, MS | December 1, 2012

Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)

Online Medical Information Adds New Dimension to Patients’ Discussions with Doctors

Vanessa Caceres | December 1, 2012

Patients and rheumatologists find pros and cons in Web-based research